z-logo
open-access-imgOpen Access
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Author(s) -
E. Louw
Publication year - 2021
Publication title -
african journal of thoracic and critical care medicine
Language(s) - English
Resource type - Journals
eISSN - 2617-0205
pISSN - 2617-0191
DOI - 10.7196/ajtccm.2021.v27i1.140
Subject(s) - nintedanib , medicine , mycophenolate , interstitial lung disease , subgroup analysis , lung , gastroenterology , idiopathic pulmonary fibrosis , meta analysis , transplantation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here